Nyt fra tidsskrifterne
47 ud af 47 tidsskrifter valgt, søgeord (tuberculosis, tuberkulose) valgt, emner højest 30 dage gamle, sorteret efter nyeste først.
71 emner vises.
1
Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study
Clinical Infectious Diseases
Tilføjet 14.03.2025
2
Cost-effectiveness analysis comparing QuantiFERON test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent children under 15 years of age in Colombia
BMJ Open
Tilføjet 14.03.2025
3
Care for adolescents with drug-susceptible pulmonary tuberculosis in Lima, Peru: a qualitative assessment
BMJ Open
Tilføjet 14.03.2025
4
S-nitrosylation-triggered secretion of mycobacterial PknG leads to phosphorylation of SODD to prevent apoptosis of infected macrophages
Proceedings of the National Academy of Sciences
Tilføjet 14.03.2025
5
Candidate transmission survival genome of Mycobacterium tuberculosis
Proceedings of the National Academy of Sciences
Tilføjet 14.03.2025
6
Multi‐drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam
Tropical Medicine & International Health
Tilføjet 13.03.2025
7
Diagnostic tests for tuberculosis infection and predictive indicators of disease progression: utilizing host and pathogen biomarkers to enhance the TB elimination strategies
International Journal of Infectious Diseases
Tilføjet 13.03.2025
8
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study
Infection
Tilføjet 12.03.2025
9
Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia
PLoS One Infectious Diseases
Tilføjet 11.03.2025
10
Clustering and modeling joint-trajectories of HIV/AIDS and tuberculosis mortality rates using bayesian multi-process latent growth model: A global study from 1990 to 2021
BMC Infectious Diseases
Tilføjet 11.03.2025
11
Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing
BMC Infectious Diseases
Tilføjet 11.03.2025
12
Host-directed therapy in diabetes and tuberculosis comorbidity, towards global TB elimination
International Journal of Infectious Diseases
Tilføjet 10.03.2025
13
Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality
International Journal of Infectious Diseases
Tilføjet 9.03.2025
14
Scaling-up symptom-agnostic, community-wide screening towards global tuberculosis elimination: opportunities, challenges and lessons from history
International Journal of Infectious Diseases
Tilføjet 9.03.2025
15
Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection
Proceedings of the National Academy of Sciences
Tilføjet 7.03.2025
16
[Seminar] Tuberculosis
Lancet
Tilføjet 7.03.2025
17
Improved detection of extrapulmonary and paucibacillary pulmonary tuberculosis by Xpert MTB Host Response in a TB low endemic, high resource setting
Journal of Infectious Diseases
Tilføjet 6.03.2025
18
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
BMJ Open
Tilføjet 6.03.2025
19
Primary cutaneous mixed infection with Cryptococcus uniguttulatus and Mycobacterium tuberculosis
BMC Infectious Diseases
Tilføjet 6.03.2025
20
Completion of tuberculosis preventive treatment with 300 mg vs. 100 mg isoniazid tablets: a pragmatic randomized clinical trial
BMC Infectious Diseases
Tilføjet 6.03.2025
21
[Articles] Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
Lancet Infectious Diseases
Tilføjet 6.03.2025
22
Multicenter, retrospective cohort study of antimycobacterial treatment-related harms among patients with non-tuberculosis Mycobacterium infections in the United States
Antimicrobial Agents And Chemotherapy
Tilføjet 5.03.2025
23
Emerging evidence to reduce the burden of tuberculosis in children and young people
International Journal of Infectious Diseases
Tilføjet 5.03.2025
24
Patients acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania
BMJ Open
Tilføjet 5.03.2025
25
Primary cutaneous mixed infection with Cryptococcus uniguttulatus and Mycobacterium tuberculosis
BMC Infectious Diseases
Tilføjet 5.03.2025
26
[Spotlight] How Glasgow's 1957 tuberculosis screening programme could help countries today
Lancet Respiratory Medicine
Tilføjet 5.03.2025
27
Correction: Computational reassessment of RNA-seq data reveals key genes in active tuberculosis
PLoS One Infectious Diseases
Tilføjet 4.03.2025
28
Completion of tuberculosis preventive treatment with 300 mg vs. 100 mg isoniazid tablets: a pragmatic randomized clinical trial
BMC Infectious Diseases
Tilføjet 4.03.2025
29
Research - Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United States
Emerging Infectious Diseases
Tilføjet 1.03.2025
30
Research - Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Emerging Infectious Diseases
Tilføjet 1.03.2025
31
Four months daily rifampicin versus three months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: a randomized controlled trial
Clinical Microbiology and Infection
Tilføjet 1.03.2025
32
Investigator-initiated randomized clinical trials in infectious diseases: the BALANCE experience
Clinical Microbiology and Infection
Tilføjet 1.03.2025
33
Long-term outcomes of patients with central nervous system tuberculosis in a high-income country: a retrospective study
Clinical Microbiology and Infection
Tilføjet 1.03.2025
34
C-Reactive Protein for Tuberculosis Triage Testing Is Not the Answer for Some Populations—Did We Ask the Right Question?
American Journal of Respiratory and Critical Care Medicine
Tilføjet 1.03.2025
35
C-Reactive Protein–based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study
American Journal of Respiratory and Critical Care Medicine
Tilføjet 1.03.2025
36
Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis
BMC Infectious Diseases
Tilføjet 1.03.2025
37
Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis
Clinical Infectious Diseases
Tilføjet 1.03.2025
38
Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan
Clinical Infectious Diseases
Tilføjet 28.02.2025
39
Health inequalities in respiratory tract infections – beyond COVID-19
Current Opinion in Infectious Diseases
Tilføjet 27.02.2025
40
Tuberculosis molecular bacterial load assay in the management of tuberculosis
Current Opinion in Infectious Diseases
Tilføjet 27.02.2025
41
A bacterial effector manipulates host lysosomal protease activity–dependent plasticity in cell death modalities to facilitate infection
Proceedings of the National Academy of Sciences
Tilføjet 27.02.2025
42
Amoxicillin-induced bacterial gut dysbiosis decreases IL-1β and IL-6 expression but exacerbate lung inflammatory response against Mycobacterium bovis—Bacille Calmette-Guérin (BCG)
PLoS One Infectious Diseases
Tilføjet 27.02.2025
43
Optimizing phage therapy for carbapenem-resistant Enterobacter cloacae bacteremia: insights into dose and timing
Antimicrobial Agents And Chemotherapy
Tilføjet 26.02.2025
44
Clinical characteristics and treatment outcomes of opportunistic infections in advanced HIV disease patients among men who have sex with men in Vietnam: A prospective cross-sectional study
BMC Infectious Diseases
Tilføjet 26.02.2025
45
mHealth intervention (mTB-Tobacco) for smoking cessation in people with drug-sensitive pulmonary tuberculosis in Bangladesh and Pakistan: protocol for an adaptive design, cluster randomised controlled trial (Quit4TB)
BMJ Open
Tilføjet 25.02.2025
46
Update on MDR-TB preventive therapy towards the global TB elimination
International Journal of Infectious Diseases
Tilføjet 22.02.2025
47
Enhancing programmatic scale-up: Applying the consolidated framework for implementation research to evaluate decentralized drug-resistant tuberculosis services in Southern Nigeria
PLoS One Infectious Diseases
Tilføjet 22.02.2025
48
Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis
Clinical Infectious Diseases
Tilføjet 20.02.2025
49
T-Racing: a modern tool for supporting epidemiological investigation in animal disease outbreaks in Italy
PLoS One Infectious Diseases
Tilføjet 20.02.2025
50
Necrosis drives susceptibility to Mycobacterium tuberculosis in PolgD257A mutator mice
Infection and Immunity
Tilføjet 20.02.2025